Fundz

Adcytherix raised $32.2m in a seed funding round led by Pontifax Venture Capital to develop ADCs for cancer treatment

PRIVATEJun 11, 2024

Amount Raised

$32.2 Million

Round Type

Seed

MarseilleBiotechnologyHealth Careresearch

Investors

Dawn BiopharmaPureos BioventuresRA Capital ManagementPontifax Venture Capital

Description

France-based biopharmaceutical company Adcytherix has announced its launch with seed funding of €30m ($32.2m) aimed at developing new antibody-drug conjugates (ADCs) for cancer treatment. The company will focus on the development of ADCs targeting diseases with significant unmet medical needs. Jack Elands, Pontifax Venture Capital, RA Capital Management, Pureos Bioventures, and Dawn Biopharma led the funding round.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Adcytherix that raised within 45 days of this round, from Fundz verified event records.

  • FOXO Technologies raised $290K on July 17, 2024.
  • FOXO Technologies raised $235K on July 17, 2024.
  • Climb Bio, Inc. raised $120M on June 27, 2024.
  • Climb Bio, Inc. raised $42M on June 27, 2024.
  • Aptose Biosciences raised $4.4M (Seed) on June 3, 2024.
  • Gameto raised $33M (Series B) on May 29, 2024.

Who to call at Adcytherix, and when

A new round usually means Adcytherix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Adcytherix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adcytherix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adcytherix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adcytherix

Location

17 Boulevard Augustin Cieussa

Marseille, Provence Alpes Côte D'azur, France

About

Adcytherix is a biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company was founded by Jack Elands and Pontifax Venture Capital with two other executives of Emergence Therapeutics, Xavier Preville and Carsten Dehning as cofounders. Adcytherix is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adcytherix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsJaime A., Chief Financial Officer - CFO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Adcytherix's next move

See what Strategic adds

Adcytherix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.